JP2018514522A5 - - Google Patents

Download PDF

Info

Publication number
JP2018514522A5
JP2018514522A5 JP2017553875A JP2017553875A JP2018514522A5 JP 2018514522 A5 JP2018514522 A5 JP 2018514522A5 JP 2017553875 A JP2017553875 A JP 2017553875A JP 2017553875 A JP2017553875 A JP 2017553875A JP 2018514522 A5 JP2018514522 A5 JP 2018514522A5
Authority
JP
Japan
Prior art keywords
alkyl
group
heterocyclyl
cycloalkyl
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017553875A
Other languages
English (en)
Japanese (ja)
Other versions
JP7240811B2 (ja
JP2018514522A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/027703 external-priority patent/WO2016168568A1/en
Publication of JP2018514522A publication Critical patent/JP2018514522A/ja
Publication of JP2018514522A5 publication Critical patent/JP2018514522A5/ja
Priority to JP2022205228A priority Critical patent/JP2023030103A/ja
Application granted granted Critical
Publication of JP7240811B2 publication Critical patent/JP7240811B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017553875A 2015-04-15 2016-04-15 アムホテリシンbの誘導体 Active JP7240811B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022205228A JP2023030103A (ja) 2015-04-15 2022-12-22 アムホテリシンbの誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562147949P 2015-04-15 2015-04-15
US62/147,949 2015-04-15
PCT/US2016/027703 WO2016168568A1 (en) 2015-04-15 2016-04-15 Derivatives of amphotericin b

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2021022476A Division JP2021075570A (ja) 2015-04-15 2021-02-16 アムホテリシンbの誘導体
JP2022205228A Division JP2023030103A (ja) 2015-04-15 2022-12-22 アムホテリシンbの誘導体

Publications (3)

Publication Number Publication Date
JP2018514522A JP2018514522A (ja) 2018-06-07
JP2018514522A5 true JP2018514522A5 (enExample) 2021-04-08
JP7240811B2 JP7240811B2 (ja) 2023-03-16

Family

ID=57126898

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017553875A Active JP7240811B2 (ja) 2015-04-15 2016-04-15 アムホテリシンbの誘導体
JP2021022476A Abandoned JP2021075570A (ja) 2015-04-15 2021-02-16 アムホテリシンbの誘導体
JP2022205228A Pending JP2023030103A (ja) 2015-04-15 2022-12-22 アムホテリシンbの誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021022476A Abandoned JP2021075570A (ja) 2015-04-15 2021-02-16 アムホテリシンbの誘導体
JP2022205228A Pending JP2023030103A (ja) 2015-04-15 2022-12-22 アムホテリシンbの誘導体

Country Status (7)

Country Link
US (3) US9957290B2 (enExample)
EP (2) EP3283171B1 (enExample)
JP (3) JP7240811B2 (enExample)
CA (2) CA3213127A1 (enExample)
ES (1) ES2880029T3 (enExample)
PT (1) PT3283171T (enExample)
WO (1) WO2016168568A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102548341B1 (ko) 2013-10-07 2023-06-26 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 개선된 치료 지수를 갖는 암포테리신 b 유도체
MA39568A1 (fr) * 2014-06-12 2017-09-29 Shionogi & Co Dérivé de macrolide de polyène
EP3283171B1 (en) * 2015-04-15 2021-05-26 Sfunga Therapeutics, Inc. Derivatives of amphotericin b
WO2017100171A1 (en) * 2015-12-08 2017-06-15 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
WO2018106571A1 (en) * 2016-12-06 2018-06-14 Kalyra Pharmaceuticals, Inc. Antifungal compounds and methods
CN113056274A (zh) * 2018-09-07 2021-06-29 伊利诺伊大学评议会 具有降低的毒性的杂化两性霉素b衍生物
WO2021026450A1 (en) * 2019-08-08 2021-02-11 The Board Of Trustees Of The University Of Illinois Hybrid amphotericin b derivatives with reduced toxicity
KR20220071185A (ko) * 2019-08-08 2022-05-31 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 암포테리신 b의 하이브리드 아미드 유도체
WO2022003181A1 (fr) * 2020-07-03 2022-01-06 Nanotracks Diagnostics Derivés urée de l'amphotéricine amb, compositions les contenant et leurs utilisations, dérivés isocyanate d'alkyle omega-aminés et leur utilisation pour obtenir lesdits dérivés urée
FR3112145A1 (fr) * 2020-07-03 2022-01-07 Nanotracks Diagnostics Derives uree de macrolides polyeniques, composes chimiques particuliers susceptibles d’etre utilises pour obtenir ces derives uree, compositions les contenant et utilisations
MX2023001649A (es) * 2020-08-10 2023-04-24 Univ Illinois Derivados de amida hibrida de anfotericina b.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8829592D0 (en) 1988-12-19 1989-02-08 Beecham Group Plc Novel compounds
EP0350164A3 (en) * 1988-06-13 1991-07-24 Beecham Group Plc Amphotericin derivatives
EP0431870A1 (en) 1989-12-08 1991-06-12 Beecham Group p.l.c. Amphotericin B derivatives
NZ241954A (en) 1991-03-15 1994-01-26 Amgen Inc Compositions of g-csf for pulmonary administration.
GB9203476D0 (en) * 1992-02-19 1992-04-08 Smithkline Beecham Plc Novel compounds
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
US5606038A (en) 1995-04-10 1997-02-25 Competitive Technologies, Inc. Amphiphilic polyene macrolide antibiotic compounds
PL180253B1 (pl) * 1995-05-13 2001-01-31 Politechnika Gdanska Pochodne N-metylo-N-glikozylowe estrów metylowych antybiotyków z grupy makrolidów polienowych i ich sole oraz sposób ich otrzymywania PL PL PL PL PL PL
US6664241B2 (en) * 2000-05-31 2003-12-16 Micrologix Biotech Inc. Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
EP1987049A1 (en) * 2006-02-23 2008-11-05 ETH Zürich Amphotericin derivatives
JP5240704B2 (ja) * 2007-10-05 2013-07-17 国立大学法人群馬大学 新規蛍光化合物およびそれを用いた細胞内コレステロールの検出方法
BR112014031060A2 (pt) 2012-06-15 2017-06-27 Blirt S A composto de fórmula 1a; composição farmacêutica; uso do composto; método para tratamento de infecção fúngica em um paciente; produto de proteção de planta; método para tratamento de infecção fúngica em uma planta; produto de tratamento de edifício antifúngico; método para tratamento de um edifício; e composto para uso
WO2014165676A1 (en) 2013-04-03 2014-10-09 The Board Of Trustees Of The University Of Illinois Amphotericin b derivative with reduced toxicity
KR102548341B1 (ko) * 2013-10-07 2023-06-26 더 보오드 오브 트러스티스 오브 더 유니버시티 오브 일리노이즈 개선된 치료 지수를 갖는 암포테리신 b 유도체
WO2015164289A1 (en) * 2014-04-21 2015-10-29 Cidara Therapeutics, Inc. Compositions and methods for the treatment of fungal infections
WO2015175875A1 (en) 2014-05-16 2015-11-19 The Board Of Trustees Of The University Of Illinois Amphotericin b derivative with reduced toxicity
MA39568A1 (fr) 2014-06-12 2017-09-29 Shionogi & Co Dérivé de macrolide de polyène
WO2016014779A1 (en) 2014-07-23 2016-01-28 The Board Of Trustees Of The University Of Illinois Antifungal polyene macrolide derivatives with reduced mammalian toxicity
WO2016040779A1 (en) 2014-09-12 2016-03-17 The Board Of Trustees Of The University Of Illinois Urea derivatives of polyene macrolide antibiotics
WO2016061437A1 (en) 2014-10-17 2016-04-21 The Board Of Trustees Of The University Of Illinois Scalable synthesis of reduced toxicity derivative of amphotericin b
WO2016112243A1 (en) 2015-01-08 2016-07-14 The Board Of Trustees Of The University Of Illinois Urea derivatives of amphotericin b derived from secondary amines
AU2016205187B2 (en) 2015-01-08 2020-02-27 The Board Of Trustees Of The University Of Illinois Concise synthesis of urea derivatives of amphotericin B
EP3283171B1 (en) * 2015-04-15 2021-05-26 Sfunga Therapeutics, Inc. Derivatives of amphotericin b

Similar Documents

Publication Publication Date Title
JP2018514522A5 (enExample)
RU2020131276A (ru) Терапевтические соединения и композиции
JP2012092103A5 (enExample)
JP2019510810A5 (enExample)
JP2017527561A5 (enExample)
JP2012140432A5 (enExample)
JP2016537382A5 (enExample)
JP2017526674A5 (enExample)
JP2015143283A5 (enExample)
WO2018013430A3 (en) Heterocyclic compounds for the treatment of arenavirus infection
JP2015516427A5 (enExample)
WO2016071293A3 (en) Pharmaceutical compound
JP2014526533A5 (enExample)
JP2012532136A5 (enExample)
JP2015042636A5 (ja) 有機化合物
WO2017106429A3 (en) Bipyrazolyl derivatives useful for the treatment of autoimmune diseases
JP2013520443A5 (enExample)
BR112016025356A2 (pt) 4-fenilpiperidinas substituido, sua preparação e utilização
JP2011513410A5 (enExample)
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
JP2020532545A5 (enExample)
RU2017103656A (ru) Производные изоиндолинона, полезные в качестве противовирусных средств
JP2015500842A5 (enExample)
JP2015199738A5 (enExample)
RU2017145357A (ru) Пролекарство на основе фосфамида монобензилового сложного эфира тенофовира, способ его получения и применение